Bio Diagnostics Company Investment Opportunity in Gurgaon, India

- The company has pioneered the first blood-based cancer detection tests capable of identifying up to 30 common cancers.
- We have consistently focused on innovative solutions for early-stage cancer detection to significantly reduce cancer-related deaths.
- The company employs an ingenious approach that combines cutting-edge experimental tools with the latest advancements in deep learning methodologies.
- With the global rise in cancer incidence, annual cancer deaths have also increased significantly.
- Most cancers are diagnosed at late stages due to the absence of early clinical symptoms, leading to poor prognosis.
- Early detection of cancer can reduce mortality by up to 70%, yet no current methods accurately detect cancer at early stages.
- We have leveraged this opportunity by developing a groundbreaking blood test that detects 30 cancers in both males and females.
- Our product integrates molecular mapping of the physiological state with a deep learning platform to identify cancer-specific molecular signatures.
- The test is a novel, non-invasive blood-based screening method capable of detecting cancers and identifying the tissue of origin from the same sample.
- The 30 cancers detected represent about 90% of new cancer cases each year.
- Our test has achieved an unmatched accuracy of over 98% for early-stage cancer detection.
- This advancement can significantly reduce the global cancer mortality burden.
- The company is in the process of commercializing the test.
- The promoter have over 40+ years of experience in the industry.
- Licenses include CIN, SSM and GST. We have also applied for a USFDA. We have applied to the DCGI (Drugs Controller General of India) for market approval in India. We will launch operations post the DCGI approval.
- Our target audience includes hospitals in India and Singapore.
- Our R&D headquarters are in Haryana, with global headquarters in Singapore.
- We also maintain an office in Singapore with dedicated staff.